Capricor Therapeutics
CAPR
#5589
Rank
A$1.83 B
Marketcap
A$33.75
Share price
-2.35%
Change (1 day)
51.82%
Change (1 year)

Earnings for Capricor Therapeutics (CAPR)

Earnings in 2025 (TTM): -A$0.13 Billion

According to Capricor Therapeutics 's latest financial reports the company's current earnings are A$11.13 Million. In 2024 the company made an earning of -A$56.79 Million a decrease over its 2023 earnings that were of -A$31.28 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Capricor Therapeutics from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$0.13 Billion123.79%
2024 -A$56.79 Million81.57%
2023 -A$31.28 Million-23.2%
2022 -A$40.73 Million44.93%
2021 -A$28.1 Million46.61%
2020 -A$19.17 Million78.71%
2019 -A$10.73 Million-49.7%
2018 -A$21.32 Million-724.78%
2017 A$3.41 M-112.93%
2016 -A$26.39 Million46.27%
2015 -A$18.05 Million106.82%
2014 -A$8.73 Million-48.41%
2013 -A$16.91 Million977.23%
2012 -A$1.57 Million-77.11%
2011 -A$6.86 Million-22.35%
2010 -A$8.84 Million-20.17%
2009 -A$11.07 Million-41.17%
2008 -A$18.81 Million41.05%
2007 -A$13.34 Million1098.87%
2006 -A$1.12 Million4101.55%
2005 -A$0.03 Million-0.97%
2004 -A$0.03 Million17.87%
2003 -A$0.03 Million3.66%
2002 -A$0.03 Million-30.11%
2001 -A$0.04 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$45.45 B-39,612.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
A$0.81 B-811.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-A$1.06 Billion 817.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-A$0.36 Billion 212.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-A$6.73 Million-94.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-A$13.32 Million-88.43%๐Ÿ‡บ๐Ÿ‡ธ USA